GL1X · GenesisL1 explorer

MolNFT v1 · #51677 · protein

Structure-based enzyme engineering efforts with an inactive monomeric tim variant: the importance of a single point mutation for generating an active site with suitable binding properties

2VEN · Glycosomal triosephosphate isomerase: “Structure-based enzyme engineering efforts with an inactive monomeric tim variant: the importance of a single…”. X-ray diffraction, 5 pockets (best druggability 0.83). MolNFT v1 #51677 on…

PDB
2VEN
Type
protein
Length
466 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycosomal triosephosphate isomerase
EC
5.3.1.1
UniProt
P04789
Pockets
5 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 47% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycosomal triosephosphate isomerase (EC 5.3.1.1)protein22847% helix, 17% strandP04789
BGlycosomal triosephosphate isomerase (EC 5.3.1.1)protein23846% helix, 17% strandP04789

Ligands and binding sites

  • CIT · Citric acid · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19970.830.8485empty
21500.500.7926CIT
3510.340.7921empty
4590.300.7513empty
5510.290.7611empty

Interfaces

1 interface between chains.

  • A–B · 642 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 2VEN · Structure-based enzyme engineering efforts with an inactive monomeric TIM variant: the… · the same entry in another collection · chain A against A, TM-score 1.00
  • 4TIM · Crystallographic and molecular modeling studies on trypanosomal triosephosphate… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.